Anticancer Agents in Medicinal Chemistry

Formerly Current Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-cancer agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in cancer medicinal chemistry. Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery

  •  Design and synthesis of target compounds: thiazoles, thiophenes, benzimidazoles and   boronic acid derivatives as anticancer and anti-diabetic agents
  •  Synthesis of neuroprotective and multi target directed ligand molecules and their pharmacokinetic/pharmacodynamic (PK/PD) studies
  •  Ionic liquid mediated C-C and C=C bond forming reactions
  •  Re purposing of existing drug molecules for improved PK/PD profiling by modification of non pharmacophoric parts
  •   Transition metal catalyzed C-H activation reactions of unreactive (C(sp2)-H, C(sp3)-H bond) for the synthesis of anticancer agents

Related Conference of Anticancer Agents in Medicinal Chemistry

April 17-18, 2024

14th International Conference on Chemistry Meeting

Paris, France
June 25-26, 2024

13th World Congress on Chromatography

Toronto, Canada
August 22-23, 2024

16th International Conference on Clinical Chemistry

Berlin, Germany
December 18-19, 2024

4th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Anticancer Agents in Medicinal Chemistry Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in